GLP-1 receptor agonists like Ozempic and Wegovy have a lot of scientific data to support their use—and they can help people ...

While GLP-1 receptor agonists are not cheap, some companies are looking at ways to make them more affordable. Eli Lilly, for example, recently announced that they would be selling vials of ...

While GLP-1 receptor agonists are not cheap, some companies are looking at ways to make them more affordable. Eli Lilly, for example, recently announced that they would be selling vials of ...

Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...

Let’s talk about insider trading. Not the illegal kind, but the perfectly normal – and fully legal – trading by top-level ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

Glucagon-like peptide-1 (GLP-1) agonists such as Ozempic ... ratio of 59 still leaves the stock far from being cheap. I think shares of Lilly have experienced outsize buying activity for two ...

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...